This video highlights our AGBT 2024 workshop on DNBSEQ™ technology’s breakthroughs in accuracy and accessibility, and a cost-effective sequencing method that identifies key germline variants in breast cancer clinic patients.
Advancing Genomics in Agriculture: The Impact of DNBSEQ™ Technology
This recording captures our PAG31 workshop, highlighting the transformative impact of DNBSEQ™ technology on Agrigenomics, improving sequencing accuracy and cost-effectiveness. The technology eliminates index hopping and clonal errors, enhancing accuracy, flexibility, and accessibility.
PCR-free whole genome sequencing with DNBSEQ™ technology
Online / Natureportfolio
PCR-free whole genome sequencing with DNBSEQ™ technology offers a direct, accurate way to analyze genomes by eliminating PCR amplification biases. This advancement enhances sequencing reliability for genetics research and clinical diagnostics, facilitating deeper genetic insights and personalized medicine.
ASHG 2023: Exclusive insights from Complete Genomics
At the American Society for Human Genetics in Washington D.C., geneticists worldwide were briefed on Complete Genomics’ DNBSEQ™ revolutionizing full genome sequencing, the use of DNBSEQ-T7 in clinical labs for structural variant detection, and a University of Massachusetts researcher’s use of STOmics’s Stereo-Seq and DNBSEQ-T7 data.
WGS for Ultrasensitive MRD Detection & Monitoring with DNA Nanoball Sequencing
Online / GenomeWeb
The integration of Whole Genome Sequencing (WGS) for ultrasensitive detection and
monitoring of Minimal Residual Disease (MRD) through DNA Nanoball Sequencing represents a significant advancement in cancer diagnostics.
Get in Touch
Whether you have questions about our products, need assistance with genomic solutions, or just want to learn more about our technology, our team is ready to assist.